Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition

Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
kdunleavy
Fri, 03/18/2022 – 18:13

Source: www.fiercepharma.com – Read more